GI & Endoscopy

PvP Biologics is conducting the first in-human clinical trials for its celiac disease drug candidate Kuma062.

Here are the five most popular gastroenterology and endoscopy stories for the week of Aug. 30 to Sept. 5, 2018:

Research suggests up to 60 percent of inflammatory bowel disease patients are turning to alternative medicines to ease symptoms, and as a result, Boston-based Harvard Medical School's Adam Cheifetz, MD, said gastroenterologists should ensure patients are still taking prescribed therapies,…

The American Gastroenterological Association commended the U.S. Senate's passage of the 2019 Labor-HHS-Education Appropriations bill, which increased the National Institutes of Health's funding by $2 billion.

Fujifilm Corp. invested an undisclosed amount in Suono Bio to support the company's second-generation drug pipeline.

Eric Shapiro, MD is a gastroenterologist at University Hospitals of Cleveland.

Cantel Medical is leaving Little Falls, N.J., behind for Plymouth, Minn.

Miami-based Gastro Health closed its acquisition of Boynton Beach-based South Florida Gastroenterology Associates, rebranding the practice's several locations under the Gastro Health banner.

Check-Cap's C-Scan preparation-free colonoscopy alternative delivered promising initial results in its post-CE approval trial.

Jorge E. Rodriguez, MD, is a gastroenterologist at the West Hollywood, Calif.-based Cast Centers.